MABTAS 500MG INJ
Prescription Required
Sale price
₹ 6,900.00
Regular price
MRP: ₹ 39,994.96
83% OFF
Inclusive of all taxes.
Couldn't load pickup availability
MABTAS 500MG INJ
Regular price
₹ 6,900.00
Regular price
₹ 39,994.96
Sale price
₹ 6,900.00
(-83%)
Unit price
per
MABTAS 500MG INJ
Sale price
₹ 6,900.00
Regular price
MRP: ₹ 39,994.96
83% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Mabtas 500mg Injection contains rituximab, a monoclonal antibody that targets CD20-positive B cells to treat selected cancers and autoimmune disorders.
Uses
Mabtas 500mg Injection is used for the treatment of certain cancers and autoimmune disorders.
- Non-Hodgkin lymphoma
- Chronic lymphocytic leukaemia
- Rheumatoid arthritis
- Granulomatosis with polyangiitis
Storage
- Store refrigerated at 2°C–8°C.
- Do not freeze.
- Protect from light.
Safety Information
- Screen for hepatitis B before therapy.
- Monitor for infusion reactions and infections throughout treatment.
Possible Side Effects
Possible side effects may include:
- Infusion reactions
- Fever
- Chills
- Infections
- Nausea
- Fatigue
- Low blood cell counts
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Mabtas is a prescription biological medicine.
It should only be administered under the supervision of a qualified healthcare professional.